跳转至内容
Merck
CN
  • MUC1 extracellular domain confers resistance of epithelial cancer cells to anoikis.

MUC1 extracellular domain confers resistance of epithelial cancer cells to anoikis.

Cell death & disease (2014-10-03)
Q Zhao, T Piyush, C Chen, M A Hollingsworth, J Hilkens, J M Rhodes, L-G Yu
摘要

Anoikis, a special apoptotic process occurring in response to loss of cell adhesion to the extracellular matrix, is a fundamental surveillance process for maintaining tissue homeostasis. Resistance to anoikis characterises cancer cells and is a pre-requisite for metastasis. This study shows that overexpression of the transmembrane mucin protein MUC1 prevents initiation of anoikis in epithelial cancer cells in response to loss of adhesion. We show that this effect is largely attributed to the elongated and heavily glycosylated extracellular domain of MUC1 that protrudes high above the cell membrane and hence prevents activation of the cell surface anoikis-initiating molecules such as integrins and death receptors by providing them a mechanically 'homing' microenvironment. As overexpression of MUC1 is a common feature of epithelial cancers and as resistance to anoikis is a hallmark of both oncogenic epithelial-mesenchymal transition and metastasis, MUC1-mediated cell resistance to anoikis may represent one of the fundamental regulatory mechanisms in tumourigenesis and metastasis.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
钙黄绿素-AM, suitable for fluorescence, BioReagent, ≥90% (HPLC)
Sigma-Aldrich
钙黄绿素-AM, Small Package (20 X 50 μg ), ≥90.0% (HPLC)
Sigma-Aldrich
钙黄绿素AM 溶液, 4 mM in DMSO, ≥90% (HPLC), solution